For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole while a clear bag slowly empties into a vein. A new generation of ...

Bioengineers in South Korea have succeeded in developing an intravenous needle (IV) that can bend and flex as it enters the human body. The softening IV needle is rigid at room temperature, similar to ...

Monoclonal antibodies, the drug cocktail used to treat patients infected with COVID-19, have proven to be an invaluable tool to limit severe disease and hospitalizations since the U.S. Food and Drug ...

First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...